
BioStocks Newsletter
All our news is first published on biostock.se. You can also choose to receive daily and/or weekly news summaries by subscribing to one of our newsletters. As a registered subscriber, you can also stay updated on and receive invitations to our popular events and networking meetings.
The news sweep is a daily summary of industry news from Life Science companies on the Swedish stock exchanges. In an email that lands in your inbox before lunch on weekdays, you will receive a comprehensive editorial selection of the morning's and afternoon's most important events.
The Weekly Letter comes out at the end of each week and gives you a summary of the week's most important news from BioStock, tips on interesting and current events, analyses, reports and other reading material, as well as an overview of the most important international industry news.
International Newsletter is our biweekly newsletter in English aimed at international players, investors and people in the life science industry, although everyone is welcome to subscribe. In this newsletter we collect an editorial selection of the most important life science events in Sweden and the Nordic region.
Fill out the form to subscribe.
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles

The market is taking Trump's tariff threat in stride

The EU's new life science strategy – a step in the right direction or just fluff?
